Genflow Biosciences Plc (GENF.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.89M |
| Enterprise Value | 7.78M |
| P/E Ratio | -5.66 |
| PEG Ratio | 0.07 |
| Price/Sales Ratio | 13.13 |
| Price/Book Ratio | -16.41 |
| Enterprise/Revenue | 12.99 |
| Enterprise/EBITDA | -7.62 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -1.71 |
| Operating Margin | -1.71 |
AD
Management Effectiveness
| Return On Assets | -3.13 |
| Return On Equity | 3.32 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1,093 |
| EBITDA | -2M |
| Net Income | -1.42M |
| Diluted EPS | -0 |
Balance Sheet
| Total Cash | 111,792 |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0.45 |
| Book Value Per Share | -0 |
Price History
| 52-Week Change | 175 |
| 52-Week High | 3.12 |
| 52-Week Low | 0.55 |
| Moving Average 50 Days | 2.16 |
| Moving Average 200 Days | 2.01 |
Statistics
| Average Volume | 1.61M |
| Shares Outstanding | 566.41M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
